Search Within

Assaf Moore

Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
Groups
  1. GME, Radiation Oncology (10)
  2. Graduate Medical Education (10)
  3. Radiation Oncology, Department of (10)
  4. Epidemiology and Biostatistics (9)
  5. GDMT, Radiation Oncology (9)
  6. Gynecology Disease Management Team (9)

More Groups

People
  1. Zhigang Zhang (8)
  2. Marisa Kollmeier (7)
  3. Daniel Gorovets (6)
  4. Michael Zelefsky (6)
  5. Alexandra Dreyfuss (4)
  6. Sean McBride (4)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (2)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (3)
  2. European Urology Oncology (2)
  3. Bladder Cancer (1)
  4. Brachytherapy (1)
  5. Cancers (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. Elsevier BV (2)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Science, Inc. (1)
  5. IOS Press (1)
  6. MDPI (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes from a phase 1 dose escalation study using stereotactic body radiotherapy for patients with low- or intermediate-risk prostate cancer
    Journal Article

    Moore, A.; Kollmeier, M. A.; McBride, S. M.; Toumbacaris, N.; Zhang, Z.; Lacy-Elsayegh, A.; Dreyfuss, A.; Grossman, C. E.; Gorovets, D.; Zelefsky, M. J.
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • 40 gray in 5 fractions for salvage reirradiation of spine lesions previously treated with stereotactic body radiotherapy
    Journal Article

    Moore, A.; Zhang, Z.; Fei, T.; Zhang, L.; Accomando, L.; Schmitt, A. M.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D. Y.; more...
    Neurosurgery (2024)

    Fulltext@MSK | Save
  • Pre-brachytherapy diffusion-weighted magnetic resonance imaging (DW-MRI) response as predictor of local control in the definitive treatment of cervical cancer
    Meeting Abstract

    Moore, A.; Paudyal, R.; Elder, G.; Lakhman, Y.; White, C.; Zhang, Z.; Broach, V. A.; Liu, Y.; Damanto, A.; Cohen, G. N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Local failure after prostate SBRT predominantly occurs in the PI-RADS 4 or 5 dominant intraprostatic lesion
    Journal Article

    Gorovets, D.; Wibmer, A. G.; Moore, A.; Lobaugh, S.; Zhang, Z.; Kollmeier, M.; McBride, S.; Zelefsky, M. J.
    European Urology Oncology (2023)

    Fulltext@MSK | Save
  • Hypofractionated radiation therapy (Hypo-RT) for the treatment of localized bladder cancer
    Journal Article

    Moore, A.; Lobaugh, S. M.; Zhang, Z.; Rosenberg, J. E.; Iyer, G.; Teo, M. Y.; Bochner, B.; Donahue, T.; Nunez, D. A.; Dreyfuss, A.; more...
    Bladder Cancer (2023)

    Fulltext@MSK | Save
  • Superior post-treatment biopsy outcomes with high dose SBRT compared to high-dose conventionally fractionated IMRT for clinically localized prostate cancer
    Meeting Abstract

    Zelefsky, M. J.; Kollmeier, M. A.; White, C.; Zhang, Z.; Reuter, V.; Ehdaie, B.; Moore, A.; Samson, F.; Gorovets, D.; Damato, A. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • 40 Gray in 5 fractions for salvage re-irradiation of spine lesions previously treated with stereotactic body radiotherapy
    Meeting Abstract

    Moore, A.; Zhang, Z.; Schmitt, A.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D.; Yerramilli, D.; Xu, A. J.; Brennan, V. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Favorable toxicity of chemoradiation for muscle-invasive bladder cancer in elderly, frail patients
    Meeting Abstract

    Moore, A.; Zhang, Z.; Bochner, B. H.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Funt, S. A.; Bajorin, D. F.; Teo, M. Y.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
    Journal Article

    Gorovets, D.; Hopkins, M.; Kollmeier, M.; Moore, A.; Goel, A.; Shasha, D.; Brennan, V.; McBride, S.; Cohen, G.; Damato, A. L.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • The cost of enfortumab vedotin wastage due to vial size — A real-world analysis
    Journal Article

    Sarfaty, M.; Moore, A.; Regazzi, A. M.; Mitchell, A. P.; Rosenberg, J. E.
    Cancers (2021)

    Fulltext@MSK | Save